Melanoma genetics/genomics

Frontiers in Oncology

Volumn 3 DEC, Issue , 2013, Pages

  Eccles, Michael R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Biomarkers; Genetic pathways; Melanoma; Personalized medicine; Therapeutic targets

Indexed keywords

B RAF KINASE; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1;

BRAIN METASTASIS; CANCER GROWTH; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOMICS; GNA11 GENE; GNAQ GENE; HEREDITY; HUMAN; MELANOMA; PHENOTYPE;

EID: 84892376920     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00309     Document Type: Editorial

References (15)

1. Wangari-Talbot J, Chen S. Genetics of melanoma. Front Genet (2013) 3:330. doi: 10.3389/fgene.2012.00330.
2. Klinac D, Gray ES, Millward M, Ziman M. Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. Front Oncol (2013) 3:54. doi:10.3389/fonc.2013.00054.
3. Stones CJ, Kim JE, Joseph WR, Leung E, Marshall ES, Finlay GJ, et al. Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors. Front Genet (2013) 4:66. doi:10.3389/fgene.2013.00066.
4. Hawkes JE, Campbell J, Garvin D, Cannon-Albright L, Cassidy P, Leachman SA. Lack of GNAQ and GNA11 germ-line mutations in familial melanoma pedigrees with uveal melanoma or blue nevi. Front Oncol (2013) 3:160. doi:10.3389/fonc.2013.00160.
5. Ahn A, Eccles MR. Targeted therapy; from advanced melanoma to the adjuvant setting. Front Oncol (2013) 3:205. doi:10.3389/fonc.2013.00205.
6. Trevarton AJ, Mann MB, Knapp C, Araki H, Wren JD, Stones-Havas S, et al. MelanomaDB: a web tool for integrative analysis of melanoma genomic information to identify disease-associated molecular pathways. Front Oncol (2013) 3:184. doi:10.3389/fonc.2013.00184.
7. Reinhold WC. Commentary on "MelanomaDB: a web tool for integrative analysis of melanoma genomic information to identify disease-associated molecular pathways". Front Genet (2013) 4:156. doi:10.3389/fgene.2013.00156.
8. Kim JE, Finlay GJ, Baguley BC. The role of the Hippo pathway in melanocytes and melanoma. Front Oncol (2013) 3:123. doi:10.3389/fonc.2013.00123.
9. Kim JE, Leung E, Baguley BC, Finlay GJ. Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines. Front Genet (2013) 4:97. doi:10.3389/fgene.2013.00097.
10. Eccles MR, He S, Ahn A, Slobbe LJ, Jeffs AR, Yoon H-S, et al. MITF and PAX3 play distinct roles in melanoma cell migration; outline of a "genetic switch" theory involving MITF and PAX3 in proliferative and invasive phenotypes of melanoma. Front Oncol (2013) 3:229. doi:10.3389/fonc.2013.00229.
11. Dye DE, Medic S, Ziman M, Coombe DR. Melanoma biomolecules: independently identified but functionally intertwined. Front Oncol (2013) 3:252. doi:10.3389/fonc.2013.00252.
12. Awasthi A, Woolley AG, Lecomte FJ, Hung N, Baguley BC, Wilbanks SM, et al. Variable expression of GLIPR1 correlates with invasive potential in melanoma cells. Front Oncol (2013) 3:225. doi:10.3389/fonc.2013.00225.
13. Joshi P, Zborowski M, Triozzi PL. Circulating melanoma cells: scoping the target. Front Oncol (2013) 3:189. doi:10.3389/fonc.2013.00189.
14. Yashin AI, Wu D, Arbeev KG, Kulminski AM, Stallard E, Ukraintseva SV. Why does melanoma metastasize into the brain? Genes with pleiotropic effects might be the key. Front Genet (2013) 4:75. doi:10.3389/fgene.2013.00075.
15. Gaziel-Sovran A, Osman I, Hernando E. In vivo modeling and molecular characterization: a path toward targeted therapy of melanoma brain metastasis. Front Oncol (2013) 3:127. doi:10.3389/fonc.2013.00127.